Enhanced targeting with heterobivalent ligands.
Xu L, Vagner J, Josan J, Lynch RM, Morse DL, Baggett B, Han H, Mash EA, Hruby VJ, Gillies RJ.
Xu L, et al. Among authors: morse dl.
Mol Cancer Ther. 2009 Aug;8(8):2356-65. doi: 10.1158/1535-7163.MCT-08-1183. Epub 2009 Aug 11.
Mol Cancer Ther. 2009.
PMID: 19671749
Free PMC article.